Allogene Therapeutics appoints Douglas as General Counsel
PremiumThe FlyAllogene Therapeutics appoints Douglas as General Counsel
1y ago
AMTI Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
AMTI Upcoming Earnings Report: What to Expect?
1y ago
Is AMTI a Buy, Before Earnings?
Premium
Pre-Earnings
Is AMTI a Buy, Before Earnings?
2y ago
Applied Molecular Transport presents additional data from FILLMORE trial
PremiumThe FlyApplied Molecular Transport presents additional data from FILLMORE trial
2y ago
Applied Molecular Transport downgraded to Underperform from Hold at Jefferies
Premium
The Fly
Applied Molecular Transport downgraded to Underperform from Hold at Jefferies
2y ago
BofA double downgrades Applied Molecular with upside catalysts removed
Premium
The Fly
BofA double downgrades Applied Molecular with upside catalysts removed
2y ago
Applied Molecular Transport downgraded to Market Perform from Outperform at JMP Securities
PremiumThe FlyApplied Molecular Transport downgraded to Market Perform from Outperform at JMP Securities
2y ago
Applied Molecular Transport downgraded to Market Perform at JMP Securities
Premium
The Fly
Applied Molecular Transport downgraded to Market Perform at JMP Securities
2y ago
Applied Molecular Transport announces phase 2 results from Oral AMT-101 trial
Premium
The Fly
Applied Molecular Transport announces phase 2 results from Oral AMT-101 trial
2y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100